Fifty 1 Labs, Inc. FITY
0.00 USD 0.00 (+33.33%)
At closeNov 9, 2026, 4:00 PM EST
0.0001 Day range 0.0001
0.0001 52-week range 0.0016
- YTD
- -60.00%
- 1 year
- -84.62%
News
accessnewswire.com Fifty 1 Labs, Inc. Acquires MSK Signal Recovery Product Line to Accelerate Growth in the Peptide and Musculoskeletal Health Market Acquisition expands Fifty 1 Labs' portfolio with a five-product musculoskeletal recovery platform focused on injury recovery, rehabilitation, connective tissue support, joint health, and…
accessnewswire.com Fifty 1 Labs Outlines Planned U.S. Telehealth Peptide Services Platform Model expected to include digital intake, clinician evaluation, prescription routing, monitoring coordination, and subscription-based patient support VANCOUVER, BC / ACCESS Newswire / August 7, 2026…
accessnewswire.com Fifty 1 Labs Announces Strategic Evolution into Peptide Biotechnology and Telehealth Company outlines dual platform spanning peptide R&D, AI-enabled discovery, and planned U.S. telehealth peptide services VANCOUVER, BC / ACCESS Newswire / July 10, 2026 / Fifty 1 Labs, Inc.…
accessnewswire.com Fifty 1 Labs, Inc. Accelerates Peptide Biotechnology Push into Musculoskeletal Health AI-Enabled Discovery and Clinical-Stage Development Target Injury Recovery, Performance, and Tissue Healing VANCOUVER, BC / ACCESS Newswire / April 15, 2026 / Fifty 1 Labs, Inc. (OTC:FITY), powered…
accessnewswire.com Fifty 1 Labs, Inc. Eliminates 612 Million Shares from the Market Company Retires 1,748,933 Series B Preferred Shares, Permanently Blocking Conversion into 612,126,550 Common Shares - Bought Back with Company Funds VANCOUVER, BC / ACCESS Newswire / April 14, 2026 /…
globenewswire.com Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace VANCOUVER, British Columbia, Jan. 05, 2026 (GLOBE NEWSWIRE) -- via IBN -- Fifty1 Labs, Inc. (OTC: FITY ) today issues the following clarification regarding its press release dated August 26, 2025,…
globenewswire.com Fifty 1 Labs Inc. Appoints Dr. Joel Gagnier as Chief Science Officer Pioneering Evidence-Based AI Innovation in Personalized Wellness and Health Research Pioneering Evidence-Based AI Innovation in Personalized Wellness and Health Research
globenewswire.com Fifty 1 Labs Inc. Signs Letter of Intent to Acquire BioSpark AI Technologies Inc. Strategic Acquisition Bolsters AI-Driven Healthcare Innovation, Positioning Fifty 1 Labs as a Leader in Clinical Data Analytics Strategic Acquisition Bolsters AI-Driven Healthcare Innovation,…
globenewswire.com Fifty 1 Labs, Inc. Engages PCAOB Auditing Firm to Prepare for Uplist to OTCQB Fifty 1 Labs continues to advance its portfolio of biotech and wellness initiatives Fifty 1 Labs continues to advance its portfolio of biotech and wellness initiatives
globenewswire.com Fifty1 Labs, Inc. Leadership Publishes Landmark Framework to Unlock Global Oncology Data Through AI-Driven Real-World Evidence Leadership Team's Technical Primer Enhances Real-World Evidence (RWE) for Cross-Border Impact, Positioning Fifty1 AI Labs in a $48B Market Opportunity Leadership Team's Technical Primer Enhances…
globenewswire.com Fifty1 Labs Partners with LUNR Aerospace to Pioneer AI-Driven Drug Repurposing for Space Medicine, Strategic Collaboration Aims to Harness AI and Orbital Access to Revolutionize Astronaut Health Solutions in a $2 Billion Market by 2032 VANCOUVER, British Columbia, Aug. 26, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 AI Labs, a subsidiary of Fifty 1 Labs, Inc. ( OTC: FITY ), has entered a groundbreaking partnership with LUNR…
globenewswire.com Fifty 1 Labs, Inc. and The Gates Foundation Lead Largest-Ever Sickle Cell Disease Study, Unlocking Pathways for Gene-Based and Repurposed Therapies Landmark AI-driven analysis backed by The Gates Foundation sets stage for transformative treatments in one of the world's most underserved diseases Landmark AI-driven analysis backed by The Gates…
globenewswire.com Fifty1 Labs, Inc. and BioSpark AI Unlock 2,000+ Real-World Treatment Pathways to Accelerate Functional Medicine Innovation Strategic partnership and planned acquisition position Fifty1 Labs to dominate AI-driven drug repurposing and wellness therapeutics at scale Strategic partnership and planned acquisition position…
globenewswire.com Fifty 1 Labs, Inc. (FITY) Sparks AI Breakthrough in Drug Repurposing: Subsidiary Fifty1 AI Labs Announces Strategic Partnership with Intent to Acquire BioSpark AI Technologies SEATTLE, July 17, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty1 AI Labs, LLC, an innovative subsidiary of Fifty 1 Labs, Inc. ( OTC: FITY ), is thrilled to announce a strategic partnership with an intent…
globenewswire.com Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership Pioneering a New Era in Healthcare: AI-Driven Innovation Unlocks Transformative Therapies and Drives Path to $50M Valuation Pioneering a New Era in Healthcare: AI-Driven Innovation Unlocks…
globenewswire.com Fifty 1 Labs, Inc. Accelerates Growth with New CEO, BioSentry Division Launch and Shareholder Dividend; Company Pursues Strategic Growth Through UAV Partnership and Targeted Acquisitions in Advanced Tech and Wellness Company Pursues Strategic Growth Through UAV Partnership and Targeted Acquisitions in Advanced Tech and Wellness Company Pursues Strategic Growth Through UAV Partnership and Targeted Acquisitions in…
prismmediawire.com UAV Corp. Drives Growth with Partnership, Dividend, New Leadership, and DART SA-70 Test Success Listened: WEWAHITCHKA, Fla., April 30, 2025 – PRISM MediaWire – UAV Corp. (OTC: UMAV), a leader in UAV and airship technology, announces a strategic partnership with Fifty 1 Labs, Inc. (OTC: FITY),…
prismmediawire.com UAV Corp Names David Dugas as President and Chief Operating Officer Seasoned Executive to Lead Operational and Strategic Growth Initiatives WEWAHITCHKA, Fla., April 17, 2025 – PRISM MediaWire – UAV Corp (OTC: UMAV), an emerging leader in dual-use aerospace and…
globenewswire.com UAV Corp and Genetic Networks Announce Strategic Collaboration to Combat Biohazards with Cutting-Edge Technology, Genetic Networks Signs MOU with UMAV MELBOURNE, Fla., April 09, 2025 (GLOBE NEWSWIRE) -- via IBN - Fifty 1 Labs, Inc. ( OTC: FITY ), through its wholly owned subsidiary Genetic Networks, a pioneer in genetic perturbation and drug…
prismmediawire.com UAV Corp and Genetic Networks Announce Strategic Collaboration to Combat Biohazards with Cutting-Edge Technology Genetic Networks Signs MOU with UMAV Listen: Wewahitchka, FL, April 08, 2025 – PRISM MediaWire – UAV Corp (OTC: UMAV), a leader in unmanned aerial vehicle (UAV) technology, and Genetic Networks, a…